- Home
- UGI vs CRL Comparison
UGI vs CRL Comparison
Compare UGI & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | UGI | CRL |
|---|---|---|
| Founded | 1940 | 1947 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Natural Gas Distribution | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.1B | 8.0B |
| IPO Year | N/A | 2000 |
Fundamental Metrics
Financial Performance| Metric | UGI | CRL |
|---|---|---|
| Price | $38.26 | $196.20 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 14 |
| Target Price | $44.00 | ★ $191.00 |
| AVG Volume (30 Days) | ★ 2.6M | 829.6K |
| Earning Date | 02-04-2026 | 11-05-2025 |
| Dividend Yield | ★ 3.93% | N/A |
| EPS Growth | ★ 147.20 | N/A |
| EPS | ★ 3.09 | N/A |
| Revenue | ★ $7,287,000,000.00 | $4,023,704,000.00 |
| Revenue This Year | $27.27 | N/A |
| Revenue Next Year | $2.85 | $1.66 |
| P/E Ratio | $12.34 | ★ N/A |
| Revenue Growth | ★ 1.07 | N/A |
| 52 Week Low | $26.73 | $91.86 |
| 52 Week High | $39.59 | $200.58 |
Technical Indicators
Market Signals| Indicator | UGI | CRL |
|---|---|---|
| Relative Strength Index (RSI) | 65.87 | 67.00 |
| Support Level | $37.76 | $194.50 |
| Resistance Level | $38.51 | $200.58 |
| Average True Range (ATR) | 0.70 | 5.11 |
| MACD | -0.13 | 1.61 |
| Stochastic Oscillator | 47.01 | 84.13 |
Price Performance
Historical ComparisonAbout UGI UGI Corporation
UGI Corp is an American holding company that, through its subsidiaries, is involved in the transport and marketing of energy and related services. Its segments include AmeriGas Propane, UGI International, Midstream & Marketing, and Utilities. The AmeriGas Propane segment consists of the propane distribution business. The UGI International segment consists of LPG distribution businesses. The Midstream & Marketing segment consists of energy-related businesses. The Utilities segment consists of the regulated natural gas and electric distribution. The company derives a majority of its revenue from the UGI International segment.
About CRL Charles River Laboratories International Inc.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.